ATE221771T1 - Perorale zusammensetzung zur kontrollierten freisetzungen in dem unteren teil des gastrointestinaltraktes - Google Patents

Perorale zusammensetzung zur kontrollierten freisetzungen in dem unteren teil des gastrointestinaltraktes

Info

Publication number
ATE221771T1
ATE221771T1 AT96906784T AT96906784T ATE221771T1 AT E221771 T1 ATE221771 T1 AT E221771T1 AT 96906784 T AT96906784 T AT 96906784T AT 96906784 T AT96906784 T AT 96906784T AT E221771 T1 ATE221771 T1 AT E221771T1
Authority
AT
Austria
Prior art keywords
composition
drug
pct
controlling agent
gastrointestinal tract
Prior art date
Application number
AT96906784T
Other languages
English (en)
Inventor
Martti Marvola
Esko Marttila
Reija Yrjoelae
Esa Lahdenpaeae
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Application granted granted Critical
Publication of ATE221771T1 publication Critical patent/ATE221771T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96906784T 1995-03-21 1996-03-20 Perorale zusammensetzung zur kontrollierten freisetzungen in dem unteren teil des gastrointestinaltraktes ATE221771T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI951316A FI98343C (fi) 1995-03-21 1995-03-21 Peroraalinen formulaatio
PCT/FI1996/000164 WO1996029058A1 (en) 1995-03-21 1996-03-20 Peroral composition for controlled release in the lower gastrointestinal tract

Publications (1)

Publication Number Publication Date
ATE221771T1 true ATE221771T1 (de) 2002-08-15

Family

ID=8543092

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96906784T ATE221771T1 (de) 1995-03-21 1996-03-20 Perorale zusammensetzung zur kontrollierten freisetzungen in dem unteren teil des gastrointestinaltraktes

Country Status (16)

Country Link
US (1) US5962024A (de)
EP (1) EP0817615B1 (de)
JP (1) JPH11502217A (de)
AT (1) ATE221771T1 (de)
AU (1) AU694849B2 (de)
CA (1) CA2213747A1 (de)
DE (1) DE69622850T2 (de)
DK (1) DK0817615T3 (de)
ES (1) ES2181874T3 (de)
FI (1) FI98343C (de)
IL (1) IL117582A (de)
NO (1) NO312705B1 (de)
NZ (1) NZ303683A (de)
PT (1) PT817615E (de)
WO (1) WO1996029058A1 (de)
ZA (1) ZA962271B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998024412A2 (en) * 1996-12-05 1998-06-11 The Board Of Trustees Of The University Of Illinois Compounds useful against diseases of the colon and methods for orally administering same
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
DE60330161D1 (de) * 2002-08-29 2009-12-31 Activbiotics Pharma Llc Rifalazil zur behandlung von infektionen mit clostridium difficile
US20050025829A1 (en) * 2003-07-29 2005-02-03 Kim Cherng-Ju Controlled drug release tablets
DE602004030931D1 (de) * 2003-11-04 2011-02-17 Supernus Pharmaceuticals Inc
US8709476B2 (en) 2003-11-04 2014-04-29 Supernus Pharmaceuticals, Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
AU2005320547B2 (en) 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
US10071060B2 (en) * 2005-07-08 2018-09-11 Bioventures, Llc Asymmetrically coated table
US20080139526A1 (en) * 2006-12-06 2008-06-12 Donald Treacy Modified release dosage forms of amoxicillin
US8357394B2 (en) * 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US7713549B2 (en) * 2006-06-30 2010-05-11 Board Of Trustees Of The University Of Arkansas Extended release perforated tablet
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
EP2334178A4 (de) 2008-10-03 2012-04-11 Falk Pharma Gmbh Zusammensetzungen und verfahren zur behandlung von darmerkrankungen mit granuliertem mesalamin
EP2368544A4 (de) * 2008-11-25 2012-08-15 Mitsubishi Tanabe Pharma Corp Rasch im mund zerfallende tablette und verfahren zu ihrer herstellung
JP6203816B2 (ja) 2012-03-29 2017-09-27 セラバイオーム，エルエルシー 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
RU2015140610A (ru) 2013-03-14 2017-04-17 ТЕРАБАЙОМ, ЭлЭлСи Направленная доставка в желудочно-кишечный тракт пробиотических микроорганизмов и/или терапевтических средств
PT3684344T (pt) * 2017-10-25 2025-08-04 Chiesi Farm Spa Comprimidos de deferiprona de libertação retardada e métodos de utilização dos mesmos
IT201800011120A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002337D0 (en) * 1990-02-02 1990-04-04 Orion Yhtymae Oy Compounds useful in treating inflammatory bowel disease
PT93637A (pt) * 1989-04-20 1990-11-20 Procter & Gamble Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
JPH0334928A (ja) * 1989-06-29 1991-02-14 Teikoku Seiyaku Kk 潰瘍性大腸炎およびクローン病治療用経口投与製剤
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
AU1587392A (en) * 1991-03-15 1992-10-21 Norwich Eaton Pharmaceuticals, Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning

Also Published As

Publication number Publication date
NO973950D0 (no) 1997-08-27
FI951316L (fi) 1996-09-22
FI98343C (fi) 1997-06-10
WO1996029058A1 (en) 1996-09-26
IL117582A0 (en) 1996-07-23
EP0817615B1 (de) 2002-08-07
US5962024A (en) 1999-10-05
ES2181874T3 (es) 2003-03-01
ZA962271B (en) 1996-09-30
DE69622850D1 (de) 2002-09-12
PT817615E (pt) 2002-12-31
AU694849B2 (en) 1998-07-30
NZ303683A (en) 1998-07-28
AU5006196A (en) 1996-10-08
EP0817615A2 (de) 1998-01-14
NO312705B1 (no) 2002-06-24
JPH11502217A (ja) 1999-02-23
NO973950L (no) 1997-08-27
DE69622850T2 (de) 2003-04-24
FI951316A0 (fi) 1995-03-21
FI98343B (fi) 1997-02-28
IL117582A (en) 2000-02-29
CA2213747A1 (en) 1996-09-26
DK0817615T3 (da) 2002-11-25

Similar Documents

Publication Publication Date Title
ATE221771T1 (de) Perorale zusammensetzung zur kontrollierten freisetzungen in dem unteren teil des gastrointestinaltraktes
DE69630375D1 (de) Pharmazeutische dosierungsform zur freisetzung im colon
DE69619668D1 (de) Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon
ID17428A (id) Sediaan farmasi da;lam bentuk kapsult bersalut yang dapat dilepas pada bagian bawah saluran pencernaan
DE69719774D1 (de) Pharmazeutische dosierungsform mit mehrfachen enterischen polymer-überzügenzur abgabe im kolon
DE69636724D1 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
ATE361061T1 (de) Beschichtungszusammensetzung zur geschmacksmaskierung
NZ511448A (en) A dosage form of diltiazem that exhibits a release rate profile corresponding to a "two peak" plasma level profile in vivo
WO2002024174A3 (en) Sustained release composition containing clarithromycin
ATE235232T1 (de) Lutschtablette zur modifizierten freisetzung von wirkstoffen im gastrointestinaltrakt
BR9806174A (pt) Péletes tendo um núcleo revestido com um antifúngico e um polìmero
DE60019116D1 (de) Neue omeprazole und (s)-omeprazole zusammensetzung
CA2268868A1 (en) Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
SE9202250D0 (sv) Controlled release morphine preparation
DE69622510D1 (de) Nifedipinzubereitung mit langanhaltender Freisetzung
DE69630215D1 (de) Diltiazem-formulierung mit gesteuerter freigabe
NZ260365A (en) Controlled release drug delivery device; solid core, delay coating, semi-permeable membrane, outer enteric coating
WO2001046615A3 (en) Photoluminescent emergency egress pathway marker system
CA2271569A1 (en) Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CA2271560A1 (en) Pharmaceutical dosage form for colonic delivery
BR9612800A (pt) Forma de dosagem farmacêutica para distribuição colÈnica.
NO992349L (no) Farmas°ytisk doseform for avlevering i tykktarmen
KR970032869A (ko) 딜티아젬의 서방형 펠렛 제형

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee